Agilon Health Price to Free Cash Flow Ratio 2020-2025 | AGL

Agilon Health price to free cash flow ratio from 2020 to 2025. Price to free cash flow ratio can be defined as

Agilon Health Price to Free Cash Flow Ratio 2020-2025 | AGL

Agilon Health price to free cash flow ratio from 2020 to 2025. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$148.1B
CVS Health (CVS)$75.9B
Elevance Health (ELV)$65B
Cencora (COR)$56.2B
DiDi Global (DIDIY)$25.7B
Labcorp Holdings (LH)$21.9B
Natera (NTRA)$18.5B
BioMerieux (BMXMF)$17.1B
EUROFINS SCIENT (ERFSF)$15.2B
ICON (ICLR)$15B
CochLear (CHEOY)$13.6B
Solventum (SOLV)$12.7B
Medpace Holdings (MEDP)$12.6B
Revvity (RVTY)$11.1B
Viatris (VTRS)$10.8B
Avantor (AVTR)$9.5B
Sonic Healthcare (SKHHY)$9.1B
Charles River Laboratories (CRL)$8.8B
HealthEquity (HQY)$8.3B
Caris Life Sciences,�Inc (CAI)$7B
Bausch + Lomb (BLCO)$5.2B
Amplifon S.p.A (AMFPF)$5.1B
BrightSpring Health Services (BTSG)$3.5B
Sotera Health (SHC)$3.4B
Surgery Partners (SGRY)$2.9B
Organon (OGN)$2.6B
GeneDx Holdings (WGS)$2.6B
Concentras Parent (CON)$2.6B
Alignment Healthcare (ALHC)$2.3B
Progyny (PGNY)$2B